Shopping Cart
Remove All
Your shopping cart is currently empty
Dynorphin A is an endogenous opioid peptide and a κ-opioid receptor (KOR) agonist, with some agonistic activity on μ- and δ-opioid receptors. It primarily functions as a neurotransmitter and regulator in the central and peripheral nervous systems, exerting analgesic and mood-regulating effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $61 | - | In Stock | |
| 5 mg | $223 | - | In Stock | |
| 10 mg | $304 | - | In Stock |
| Description | Dynorphin A is an endogenous opioid peptide and a κ-opioid receptor (KOR) agonist, with some agonistic activity on μ- and δ-opioid receptors. It primarily functions as a neurotransmitter and regulator in the central and peripheral nervous systems, exerting analgesic and mood-regulating effects. |
| In vitro | Method: Mouse striatal neurons were treated with Dynorphin A at a concentration of 10 μM, and cell viability was assessed at 0, 24, 48, and 72 hours to evaluate its effect on neuronal survival. Result: Dynorphin A treatment induced neuronal death, characterized by fragmentation and destruction of the cell body and neurites. [3] |
| In vivo | Method: A 24-hour water-deprived male rat model was used, and Dynorphin A (1 μg in 2 μL) was administered via intracerebroventricular injection to evaluate its effect on vasopressin (VP) release. Result: Dynorphin A inhibited vasopressin release within 30 minutes after injection. [5] |
| Molecular Weight | 2147.48 |
| Formula | C99H155N31O23 |
| Cas No. | 80448-90-4 |
| Smiles | C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@H]1N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC2=CC=CC=C2)NC(CNC(CNC([C@H](CC3=CC=C(O)C=C3)N)=O)=O)=O)=O)CC(C)C)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)CCCNC(=N)N)=O)CCC1)CCCCN)=O)CC(C)C)=O)CCCCN)=O)C(N[C@H](C(N[C@H](C(N[C@@H](CCC(N)=O)C(O)=O)=O)CC(N)=O)=O)CC(O)=O)=O)C=4C=5C(NC4)=CC=CC5 |
| Relative Density. | 1.46 g/cm3 (Predicted) |
| Sequence | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln |
| Sequence Short | YGGFLRRIRPKLKWDNQ |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | H2O: 80 mg/mL (37.25 mM), Sonication is recommended. DMSO: 80 mg/mL (37.25 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (1.16 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.